Ziopharm Oncology Inc entered the industry of Biological Research in 2003 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417112, which describes it as a Biological Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Biological Research. The business provides service to the B2B market.
To acquire more information, please contact Richard Bagley, President by calling (617) 259-1970 during business hours. You can also write to the business’ Headquarters at 1 1st Avenue # 34, Charlestown, Massachusetts MA 02129. You can also visit the company’s website at ziopharm.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Ziopharm Oncology Inc |
| Representative: | Richard Bagley, President |
| Place of Business: | 1 1st Avenue # 34, Charlestown, MA 02129 |
| Contact Number: | (617) 259-1970 |
| Website: | ziopharm.com |
| Type of Service: | Biological Research |
| SIC Number: | 8731 |
| NAICS Number: | 5417112 |
| Locality: | Headquarters |
| Market Type: | B2B (Business to Business) |
| Began: | 2003 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Ziopharm Oncology Inc is a company operating from Suffolk, Massachusetts providing professional Biological Research and relevant B2B variables. It was founded in 2003 and registered with the SIC code 8731 as Biological Research, and with the NAICS code 5417112 as Biological Research.
With a current employee count of 1 to 4, Ziopharm Oncology Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Richard Bagley, President at (617) 259-1970 for related queries, or to locate its Headquarters using the coordinates 42.3729,-71.05781.
The Headquarters can also be found at the street address 1 1st Avenue # 34 in Charlestown, Massachusetts 02129 and can be engaged online through the company website at ziopharm.com, the company Twitter , and Facebook page .